Charrita Ernewein
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $101.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Dexcom, Inc.$618
- Neurocrine Biosciences, Inc.$502
- Sanofi$488
- Teva Pharmaceuticals USA, Inc.$429
- Abiomed$405
- plus $4K from 23 others
What the payments were for
- Food & beverage$7,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $1,280 |
| Dexcom, Inc. | 5 | $618 |
| Neurocrine Biosciences, Inc. | 4 | $502 |
| Sanofi | 4 | $488 |
| Teva Pharmaceuticals USA, Inc. | 4 | $429 |
| Abiomed | 4 | $405 |
| Actelion Pharmaceuticals US, Inc. | 3 | $352 |
| Novo Nordisk | 3 | $337 |
| Abbott | 3 | $257 |
| E.r. Squibb & Sons, L.L.C. | 3 | $251 |
| Corcept Therapeutics | 3 | $250 |
| Amgen | 2 | $247 |
| AstraZeneca | 2 | $242 |
| Sanofi-aventis U.S. LLC | 2 | $207 |
| Arcutis Biotherapeutics, Inc. | 2 | $186 |
| Boehringer Ingelheim | 2 | $171 |
| Idorsia Pharmaceuticals US Inc | 3 | $166 |
| Boston Scientific | 1 | $129 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $124 |
| GSK | 1 | $124 |
| Axonics, Inc. | 2 | $118 |
| Bayer | 1 | $97 |
| Johnson & Johnson | 1 | $93 |
| Sanofi Pasteur Inc. | 1 | $85 |
| Lilly USA, LLC | 1 | $83 |
| Evoke Pharma, Inc. | 1 | $81 |
| Genentech USA, Inc. | 1 | $80 |
| Incyte Corporation | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$535
- VRAYLAR$474
- INGREZZA$377
- DEXCOM STELO GLUCOSE BIOSENSOR$280
- UPTRAVI$269
- OPSUMIT$269
- Korlym$227
- Impella$207
- FABRAZYME$142
- WATCHMAN FLX$129
- NEXLIZET$125
- NEXLETOL$125
- Ozempic$125
- AIMOVIG$125
- ONGENTYS$125
- CERDELGA$125
- CEREZYME$125
- NURTEC ODT$124
- TRELEGY ELLIPTA$124
- AUSTEDO$123
How this compares
$7,583 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Lutz
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.